Irinotecan and capecitabine as second-line treatment after failure for first-line infusional 24-h 5-fluorouracil/folinic acid in advanced colorectal cancer: a phase II study.
about
Chemotherapy-induced weakness and fatigue in skeletal muscle: the role of oxidative stress.Phase I/II study of bi-weekly XELIRI plus bevacizumab treatment in patients with metastatic colorectal cancer resistant to oxaliplatin-based first-line chemotherapy.A randomised phase II study of irinotecan in combination with 5-FU/FA compared with irinotecan alone as second-line treatment of patients with metastatic colorectal carcinoma.
P2860
Irinotecan and capecitabine as second-line treatment after failure for first-line infusional 24-h 5-fluorouracil/folinic acid in advanced colorectal cancer: a phase II study.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Irinotecan and capecitabine as ...... ctal cancer: a phase II study.
@ast
Irinotecan and capecitabine as ...... ctal cancer: a phase II study.
@en
type
label
Irinotecan and capecitabine as ...... ctal cancer: a phase II study.
@ast
Irinotecan and capecitabine as ...... ctal cancer: a phase II study.
@en
prefLabel
Irinotecan and capecitabine as ...... ctal cancer: a phase II study.
@ast
Irinotecan and capecitabine as ...... ctal cancer: a phase II study.
@en
P2093
P1433
P1476
Irinotecan and capecitabine as ...... ctal cancer: a phase II study.
@en
P2093
Lothar Pilz
Ralf-Dieter Hofheinz
Rüdiger Hehlmann
Sebastian Kreil
Susanne Saussele
Ulrike Gnad-Vogt
P356
10.1097/00001813-200501000-00005
P577
2005-01-01T00:00:00Z